Skip to main content
NCBI home page
Transactions of the American Clinical and Climatological Association logoLink to Transactions of the American Clinical and Climatological Association
. 1990;101:46–58. doi: 10.1007/978-94-009-0731-7_14

Apolipoproteins and metabolism in atherosclerosis.

A M Gotto Jr 1
PMCID: PMC2376482  PMID: 2486446

Full text

PDF
46

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barker W. C., Dayhoff M. O. Evolution of lipoproteins deduced from protein sequence data. Comp Biochem Physiol B. 1977;57(4):309–315. doi: 10.1016/0305-0491(77)90060-8. [DOI] [PubMed] [Google Scholar]
  2. Chan L., VanTuinen P., Ledbetter D. H., Daiger S. P., Gotto A. M., Jr, Chen S. H. The human apolipoprotein B-100 gene: a highly polymorphic gene that maps to the short arm of chromosome 2. Biochem Biophys Res Commun. 1985 Nov 27;133(1):248–255. doi: 10.1016/0006-291x(85)91868-6. [DOI] [PubMed] [Google Scholar]
  3. Chen S. H., Habib G., Yang C. Y., Gu Z. W., Lee B. R., Weng S. A., Silberman S. R., Cai S. J., Deslypere J. P., Rosseneu M. Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. Science. 1987 Oct 16;238(4825):363–366. doi: 10.1126/science.3659919. [DOI] [PubMed] [Google Scholar]
  4. Chen S. H., Yang C. Y., Chen P. F., Setzer D., Tanimura M., Li W. H., Gotto A. M., Jr, Chan L. The complete cDNA and amino acid sequence of human apolipoprotein B-100. J Biol Chem. 1986 Oct 5;261(28):12918–12921. [PubMed] [Google Scholar]
  5. Fielding C. J. Monoglyceride hydrolase activities of rat plasma and platelets. Their properties and roles in the activity of lipoprotein lipase. J Biol Chem. 1981 Jan 25;256(2):876–881. [PubMed] [Google Scholar]
  6. Forgez P., Gregory H., Young J. A., Knott T., Scott J., Chapman M. J. Identification of surface-exposed segments of apolipoprotein B-100 in the LDL particle. Biochem Biophys Res Commun. 1986 Oct 15;140(1):250–257. doi: 10.1016/0006-291x(86)91083-1. [DOI] [PubMed] [Google Scholar]
  7. Karathanasis S. K., Zannis V. I., Breslow J. L. Isolation and characterization of the human apolipoprotein A-I gene. Proc Natl Acad Sci U S A. 1983 Oct;80(20):6147–6151. doi: 10.1073/pnas.80.20.6147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kita T., Brown M. S., Bilheimer D. W., Goldstein J. L. Delayed clearance of very low density and intermediate density lipoproteins with enhanced conversion to low density lipoprotein in WHHL rabbits. Proc Natl Acad Sci U S A. 1982 Sep;79(18):5693–5697. doi: 10.1073/pnas.79.18.5693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kodama T., Freeman M., Rohrer L., Zabrecky J., Matsudaira P., Krieger M. Type I macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils. Nature. 1990 Feb 8;343(6258):531–535. doi: 10.1038/343531a0. [DOI] [PubMed] [Google Scholar]
  10. Krause B. R., Newton R. S. Apolipoprotein changes associated with the plasma lipid-regulating activity of gemfibrozil in cholesterol-fed rats. J Lipid Res. 1985 Aug;26(8):940–949. [PubMed] [Google Scholar]
  11. Lussier-Cacan S., Bard J. M., Boulet L., Nestruck A. C., Grothé A. M., Fruchart J. C., Davignon J. Lipoprotein composition changes induced by fenofibrate in dysbetalipoproteinemia type III. Atherosclerosis. 1989 Aug;78(2-3):167–182. doi: 10.1016/0021-9150(89)90221-9. [DOI] [PubMed] [Google Scholar]
  12. Schmitz G., Assmann G., Robenek H., Brennhausen B. Tangier disease: a disorder of intracellular membrane traffic. Proc Natl Acad Sci U S A. 1985 Sep;82(18):6305–6309. doi: 10.1073/pnas.82.18.6305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Segrest J. P., Jackson R. L., Morrisett J. D., Gotto A. M., Jr A molecular theory of lipid-protein interactions in the plasma lipoproteins. FEBS Lett. 1974 Jan 15;38(3):247–258. doi: 10.1016/0014-5793(74)80064-5. [DOI] [PubMed] [Google Scholar]
  14. Soria L. F., Ludwig E. H., Clarke H. R., Vega G. L., Grundy S. M., McCarthy B. J. Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. Proc Natl Acad Sci U S A. 1989 Jan;86(2):587–591. doi: 10.1073/pnas.86.2.587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sparrow J. T., Sparrow D. A., Culwell A. R., Gotto A. M., Jr Apolipoprotein E: phospholipid binding studies with synthetic peptides containing the putative receptor binding region. Biochemistry. 1985 Nov 19;24(24):6984–6988. doi: 10.1021/bi00345a035. [DOI] [PubMed] [Google Scholar]
  16. Steinbrecher U. P., Witztum J. L., Parthasarathy S., Steinberg D. Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism. Arteriosclerosis. 1987 Mar-Apr;7(2):135–143. doi: 10.1161/01.atv.7.2.135. [DOI] [PubMed] [Google Scholar]
  17. Teng B., Sniderman A. D., Soutar A. K., Thompson G. R. Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia. J Clin Invest. 1986 Mar;77(3):663–672. doi: 10.1172/JCI112360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Williams R. R., Hunt S. C., Hopkins P. N., Stults B. M., Wu L. L., Hasstedt S. J., Barlow G. K., Stephenson S. H., Lalouel J. M., Kuida H. Familial dyslipidemic hypertension. Evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension. JAMA. 1988 Jun 24;259(24):3579–3586. doi: 10.1001/jama.259.24.3579. [DOI] [PubMed] [Google Scholar]
  19. Yang C. Y., Lee F. S., Chan L., Sparrow D. A., Sparrow J. T., Gotto A. M., Jr Determination of the molecular mass of apolipoprotein B-100. A chemical approach. Biochem J. 1986 Nov 1;239(3):777–780. doi: 10.1042/bj2390777. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Transactions of the American Clinical and Climatological Association are provided here courtesy of American Clinical and Climatological Association

RESOURCES